Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus

Sergio Utrilla-Trigo(Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria), Javier Ortego(Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria)
Vaccines
June 29, 2020
10.3390/vaccines8030346
Cited by 26

Related Papers

A protective bivalent vaccine against Rift Valley fever and bluetongue
|npj Vaccines|2020|35
Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus
|PLoS ONE|2013|32
CD8 T Cell Responses to an Immunodominant Epitope within the Nonstructural Protein NS1 Provide Wide Immunoprotection against Bluetongue Virus in IFNAR <sup>−/−</sup> Mice
|Journal of Virology|2018|27